{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:48:49Z","timestamp":1772722129762,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI-16\/00232"],"award-info":[{"award-number":["PI-16\/00232"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RETIC-RIC-RD12\/0042\/0021"],"award-info":[{"award-number":["RETIC-RIC-RD12\/0042\/0021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB16\/11\/00479"],"award-info":[{"award-number":["CB16\/11\/00479"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB16\/11\/00278"],"award-info":[{"award-number":["CB16\/11\/00278"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["SAF2017-84125-R"],"award-info":[{"award-number":["SAF2017-84125-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["B2017\/BMD-3671-INFLAMUNE"],"award-info":[{"award-number":["B2017\/BMD-3671-INFLAMUNE"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00395-019-0730-5","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:15:19Z","timestamp":1553613319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Calpains mediate isoproterenol-induced hypertrophy through modulation of GRK2"],"prefix":"10.1007","volume":"114","author":[{"given":"David","family":"Aluja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4736-5010","authenticated-orcid":false,"given":"Javier","family":"Inserte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petronila","family":"Penela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"I\u00f1iguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Garcia-Dorado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/A:1006857213829","volume":"176","author":"GD Arthur","year":"1997","unstructured":"Arthur GD, Belcastro AN (1997) A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy. Mol Cell Biochem 176:241\u2013248","journal-title":"Mol Cell Biochem"},{"key":"730_CR2","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3192::AID-IMMU3192>3.0.CO;2-E","volume":"28","author":"M Bermejo","year":"1998","unstructured":"Bermejo M, Martin-Serrano J, Oberlin E, Pedraza MA, Serrano A, Santiago B, Caruz A, Loetscher P, Baggiolini M, Arenzana-Seisdedos F, Alcami J (1998) Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur J Immunol 28:3192\u20133204. \nhttps:\/\/doi.org\/10.1002\/(SICI)1521-4141(199810)28:10%3c3192:AID-IMMU3192%3e3.0.CO;2-E","journal-title":"Eur J Immunol"},{"key":"730_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1517\/14728220902721312","volume":"13","author":"MS Bhuiyan","year":"2009","unstructured":"Bhuiyan MS, Shioda N, Fukunaga K (2009) Chronic beta-AR activation-induced calpain activation and impaired eNOS-Akt signaling mediates cardiac injury in ovariectomized female rats. Expert Opin Ther Targets 13:275\u2013286. \nhttps:\/\/doi.org\/10.1517\/14728220902721312","journal-title":"Expert Opin Ther Targets"},{"key":"730_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00395-019-0726-1","volume":"114","author":"T Cao","year":"2019","unstructured":"Cao T, Fan S, Zheng D, Wang G, Yu Y, Chen R, Song LS, Fan GC, Zhang Z, Peng T (2019) Increased calpain-1 in mitochondria induces dilated heart failure in mice: role of mitochondrial superoxide anion. Basic Res Cardiol 114:17. \nhttps:\/\/doi.org\/10.1007\/s00395-019-0726-1","journal-title":"Basic Res Cardiol"},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","volume":"111","author":"C Freund","year":"2005","unstructured":"Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P, El-Jamali A, Dietz R, Scheidereit C, Bergmann MW (2005) Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 111:2319\u20132325. \nhttps:\/\/doi.org\/10.1161\/01.CIR.0000164237.58200.5A","journal-title":"Circulation"},{"key":"730_CR6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/01.RES.0000261938.28365.11","volume":"100","author":"AS Galvez","year":"2007","unstructured":"Galvez AS, Diwan A, Odley AM, Hahn HS, Osinska H, Melendez JG, Robbins J, Lynch RA, Marreez Y, Dorn GW 2nd (2007) Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Circ Res 100:1071\u20131078. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000261938.28365.11","journal-title":"Circ Res"},{"key":"730_CR7","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1074\/jbc.271.2.985","volume":"269","author":"I Garcia-Higuera","year":"1994","unstructured":"Garcia-Higuera I, Penela P, Murga C, Egea G, Bonay P, Benovic JL, Mayor F Jr (1994) Association of the regulatory beta-adrenergic receptor kinase with rat liver microsomal membranes. J Biol Chem 269:1348\u20131355. \nhttps:\/\/doi.org\/10.1074\/jbc.271.2.985","journal-title":"J Biol Chem"},{"key":"730_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1562\/2004-08-05-RA-262","volume":"81","author":"C Gelis","year":"2005","unstructured":"Gelis C, Mavon A, Vicendo P (2005) The contribution of calpains in the down-regulation of Mdm2 and p53 proteolysis in reconstructed human epidermis in response to solar irradiation. Photochem Photobiol 81:975\u2013982. \nhttps:\/\/doi.org\/10.1562\/2004-08-05-RA-262","journal-title":"Photochem Photobiol"},{"key":"730_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/physrev.00029.2002","volume":"83","author":"DE Goll","year":"2003","unstructured":"Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83:731\u2013801. \nhttps:\/\/doi.org\/10.1152\/physrev.00029.2002","journal-title":"Physiol Rev"},{"key":"730_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jmb.2007.10.006","volume":"375","author":"S Gupta","year":"2008","unstructured":"Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S (2008) Prevention of cardiac hypertrophy and heart failure by silencing of NF-\u03baB. J Mol Biol 375:637\u2013649. \nhttps:\/\/doi.org\/10.1016\/j.jmb.2007.10.006","journal-title":"J Mol Biol"},{"key":"730_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.yjmcc.2010.02.024","volume":"49","author":"V Hernando","year":"2010","unstructured":"Hernando V, Inserte J, Sartorio CL, Parra VM, Poncelas-Nozal M, Garcia-Dorado D (2010) Calpain translocation and activation as pharmacological targets during myocardial ischemia\/reperfusion. J Mol Cell Cardiol 49:271\u2013279","journal-title":"J Mol Cell Cardiol"},{"key":"730_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.phrs.2016.05.008","volume":"110","author":"J Hullmann","year":"2016","unstructured":"Hullmann J, Traynham CJ, Coleman RC, Koch WJ (2016) The expanding GRK interactome: implications in cardiovascular disease and potential for therapeutic development. Pharmacol Res 110:52\u201364. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2016.05.008","journal-title":"Pharmacol Res"},{"key":"730_CR13","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/eurheartj\/ehi429","volume":"26","author":"G Iaccarino","year":"2005","unstructured":"Iaccarino G, Barbato E, Cipolletta E, De Amicis V, Margulies KB, Leosco D, Trimarco B, Koch WJ (2005) Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J 26:1752\u20131758. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehi429","journal-title":"Eur Heart J"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/cvr\/cvs245","volume":"96","author":"J Inserte","year":"2012","unstructured":"Inserte J (2012) Calpains in the cardiovascular system. Cardiovasc Res 96:9\u201310. \nhttps:\/\/doi.org\/10.1093\/cvr\/cvs245","journal-title":"Cardiovasc Res"},{"key":"730_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccr.2010.06.015","volume":"18","author":"H Inuzuka","year":"2010","unstructured":"Inuzuka H, Tseng A, Gao D, Zhai B, Zhang Q, Shaik S, Wan L, Ang XL, Mock C, Yin H, Stommel JM, Gygi S, Lahav G, Asara J, Xiao ZX, Kaelin WG Jr, Harper JW, Wei W (2010) Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell 18:147\u2013159. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2010.06.015","journal-title":"Cancer Cell"},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"12771","DOI":"10.1074\/jbc.M111.324566","volume":"287","author":"KN Islam","year":"2012","unstructured":"Islam KN, Koch WJ (2012) Involvement of nuclear factor kappaB (NF-\u03baB) signaling pathway in regulation of cardiac G protein-coupled receptor kinase 5 (GRK5) expression. J Biol Chem 287:12771\u201312778. \nhttps:\/\/doi.org\/10.1074\/jbc.M111.324566","journal-title":"J Biol Chem"},{"key":"730_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95998","author":"PY Jean-Charles","year":"2017","unstructured":"Jean-Charles PY, Yu SM, Abraham D, Kommaddi RP, Mao L, Strachan RT, Zhang ZS, Bowles DE, Brian L, Stiber JA, Jones SN, Koch WJ, Rockman HA, Shenoy SK (2017) Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of beta-adrenergic receptor signaling. JCI Insight. \nhttps:\/\/doi.org\/10.1172\/jci.insight.95998","journal-title":"JCI Insight"},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1146\/annurev-pathol-012414-040349","volume":"11","author":"O Karni-Schmidt","year":"2016","unstructured":"Karni-Schmidt O, Lokshin M, Prives C (2016) The Roles of MDM2 and MDMX in cancer. Annu Rev Pathol 11:617\u2013644. \nhttps:\/\/doi.org\/10.1146\/annurev-pathol-012414-040349","journal-title":"Annu Rev Pathol"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cardiores.2005.04.030","volume":"67","author":"S Kawano","year":"2005","unstructured":"Kawano S, Kubota T, Monden Y, Kawamura N, Tsutsui H, Takeshita A, Sunagawa K (2005) Blockade of NF-\u03baB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovasc Res 67:689\u2013698. \nhttps:\/\/doi.org\/10.1016\/j.cardiores.2005.04.030","journal-title":"Cardiovasc Res"},{"key":"730_CR20","doi-asserted-by":"publisher","first-page":"19408","DOI":"10.1074\/jbc.M114.567206","volume":"289","author":"Y Kudo-Sakamoto","year":"2014","unstructured":"Kudo-Sakamoto Y, Akazawa H, Ito K, Takano J, Yano M, Yabumoto C, Naito AT, Oka T, Lee JK, Sakata Y, Suzuki J, Saido TC, Komuro I (2014) Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling. J Biol Chem 289:19408\u201319419. \nhttps:\/\/doi.org\/10.1074\/jbc.M114.567206","journal-title":"J Biol Chem"},{"key":"730_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCRESAHA.107.160077","volume":"102","author":"E Letavernier","year":"2008","unstructured":"Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L (2008) Targeting the calpain\/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 102:720\u2013728. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.107.160077","journal-title":"Circ Res"},{"key":"730_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/cvr\/cvs099","volume":"96","author":"E Letavernier","year":"2012","unstructured":"Letavernier E, Zafrani L, Perez J, Letavernier B, Haymann JP, Baud L (2012) The role of calpains in myocardial remodelling and heart failure. Cardiovasc Res 96:38\u201345. \nhttps:\/\/doi.org\/10.1093\/cvr\/cvs099","journal-title":"Cardiovasc Res"},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","volume":"93","author":"MJ Lohse","year":"2003","unstructured":"Lohse MJ, Engelhardt S, Eschenhagen T (2003) What is the role of beta-adrenergic signaling in heart failure? Circ Res 93:896\u2013906. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000102042.83024.CA","journal-title":"Circ Res"},{"key":"730_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1124\/mol.62.2.379","volume":"62","author":"MS Lombardi","year":"2002","unstructured":"Lombardi MS, Kavelaars A, Penela P, Scholtens EJ, Roccio M, Schmidt RE, Schedlowski M, Mayor F, Jr., Heijnen CJ (2002) Oxidative stress decreases G protein-coupled receptor kinase 2 in lymphocytes via a calpain-dependent mechanism. Mol Pharmacol 62:379\u2013388","journal-title":"Mol Pharmacol"},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1016\/j.bbadis.2014.09.004","volume":"1842","author":"E Lucas","year":"2014","unstructured":"Lucas E, Jurado-Pueyo M, Fortuno MA, Fernandez-Veledo S, Vila-Bedmar R, Jimenez-Borreguero LJ, Lazcano JJ, Gao E, Gomez-Ambrosi J, Fruhbeck G, Koch WJ, Diez J, Mayor F Jr, Murga C (2014) Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns. Biochim Biophys Acta 1842:2448\u20132456. \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2014.09.004","journal-title":"Biochim Biophys Acta"},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"27480","DOI":"10.1074\/jbc.M112.358929","volume":"287","author":"J Ma","year":"2012","unstructured":"Ma J, Wei M, Wang Q, Li J, Wang H, Liu W, Lacefield JC, Greer PA, Karmazyn M, Fan GC, Peng T (2012) Deficiency of Capn4 gene inhibits nuclear factor-kappaB (NF-\u03baB) protein signaling\/inflammation and reduces remodeling after myocardial infarction. J Biol Chem 287:27480\u201327489. \nhttps:\/\/doi.org\/10.1074\/jbc.M112.358929","journal-title":"J Biol Chem"},{"key":"730_CR27","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1128\/MCB.17.11.6437","volume":"17","author":"S Martinez-Martinez","year":"1997","unstructured":"Martinez-Martinez S, Gomez del Arco P, Armesilla AL, Aramburu J, Luo C, Rao A, Redondo JM (1997) Blockade of T cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells. Mol Cell Biol 17:6437\u20136447. \nhttps:\/\/doi.org\/10.1128\/MCB.17.11.6437","journal-title":"Mol Cell Biol"},{"key":"730_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cellsig.2017.04.002","volume":"41","author":"F Mayor Jr","year":"2018","unstructured":"Mayor F Jr, Cruces-Sande M, Arcones AC, Vila-Bedmar R, Briones AM, Salaices M, Murga C (2018) G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis. Cell Signal 41:25\u201332. \nhttps:\/\/doi.org\/10.1016\/j.cellsig.2017.04.002","journal-title":"Cell Signal"},{"key":"730_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0306-4522(98)00145-6","volume":"87","author":"C Murga","year":"1998","unstructured":"Murga C, Penela P, Zafra F, Mayor F Jr (1998) The subcellular and cellular distribution of G protein-coupled receptor kinase 2 in rat brain. Neuroscience 87:631\u2013637. \nhttps:\/\/doi.org\/10.1016\/S0306-4522(98)00145-6","journal-title":"Neuroscience"},{"key":"730_CR30","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.neuroscience.2006.05.060","volume":"141","author":"T Oka","year":"2006","unstructured":"Oka T, Walkup RD, Tamada Y, Nakajima E, Tochigi A, Shearer TR, Azuma M (2006) Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-me thylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. Neuroscience 141:2139\u20132145. \nhttps:\/\/doi.org\/10.1016\/j.neuroscience.2006.05.060","journal-title":"Neuroscience"},{"key":"730_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/CIRCRESAHA.110.239749","volume":"109","author":"C Patterson","year":"2011","unstructured":"Patterson C, Portbury AL, Schisler JC, Willis MS (2011) Tear me down: role of calpain in the development of cardiac ventricular hypertrophy. Circ Res 109:453\u2013462. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.110.239749","journal-title":"Circ Res"},{"key":"730_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.pmbts.2016.04.002","volume":"141","author":"P Penela","year":"2016","unstructured":"Penela P (2016) Chapter Three\u2014ubiquitination and protein turnover of G-protein-coupled receptor kinases in GPCR signaling and cellular regulation. Prog Mol Biol Transl Sci 141:85\u2013140. \nhttps:\/\/doi.org\/10.1016\/bs.pmbts.2016.04.002","journal-title":"Prog Mol Biol Transl Sci"},{"key":"730_CR33","doi-asserted-by":"publisher","first-page":"35238","DOI":"10.1074\/jbc.273.52.35238","volume":"273","author":"P Penela","year":"1998","unstructured":"Penela P, Ruiz-Gomez A, Castano JG, Mayor F Jr (1998) Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway. J Biol Chem 273:35238\u201335244. \nhttps:\/\/doi.org\/10.1074\/jbc.273.52.35238","journal-title":"J Biol Chem"},{"key":"730_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/cvr\/cvx073","volume":"113","author":"M Poncelas","year":"2017","unstructured":"Poncelas M, Inserte J, Aluja D, Hernando V, Vilardosa U, Garcia-Dorado D (2017) Delayed, oral pharmacological inhibition of calpains attenuates adverse post-infarction remodelling. Cardiovasc Res 113:950\u2013961. \nhttps:\/\/doi.org\/10.1093\/cvr\/cvx073","journal-title":"Cardiovasc Res"},{"key":"730_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ehf2.12005","volume":"1","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Budi Siswanto B, Sliwa K, Filippatos G (2014) Heart failure: preventing disease and death worldwide. ESC Heart Fail 1:4\u201325. \nhttps:\/\/doi.org\/10.1002\/ehf2.12005","journal-title":"ESC Heart Fail"},{"key":"730_CR36","doi-asserted-by":"publisher","first-page":"e0189469","DOI":"10.1371\/journal.pone.0189469","volume":"12","author":"FP Prado","year":"2017","unstructured":"Prado FP, Dos Santos DO, Blefari V, Silva CA, Machado J, Kettelhut IDC, Ramos SG, Baruffi MD, Salgado HC, Prado CM (2017) Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure. PLoS One 12:e0189469. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0189469","journal-title":"PLoS One"},{"key":"730_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/CIRCRESAHA.107.168336","volume":"103","author":"PW Raake","year":"2008","unstructured":"Raake PW, Vinge LE, Gao E, Boucher M, Rengo G, Chen X, DeGeorge BR Jr, Matkovich S, Houser SR, Most P, Eckhart AD, Dorn GW 2nd, Koch WJ (2008) G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res 103:413\u2013422. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.107.168336","journal-title":"Circ Res"},{"key":"730_CR38","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1161\/01.CIR.101.17.2083","volume":"101","author":"R Ramos-Ruiz","year":"2000","unstructured":"Ramos-Ruiz R, Penela P, Penn RB, Mayor F Jr (2000) Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells. Circulation 101:2083\u20132089. \nhttps:\/\/doi.org\/10.1161\/01.CIR.101.17.2083","journal-title":"Circulation"},{"key":"730_CR39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/CIRCRESAHA.115.308207","volume":"118","author":"G Rengo","year":"2016","unstructured":"Rengo G, Pagano G, Filardi PP, Femminella GD, Parisi V, Cannavo A, Liccardo D, Komici K, Gambino G, D\u2019Amico ML, de Lucia C, Paolillo S, Trimarco B, Vitale DF, Ferrara N, Koch WJ, Leosco D (2016) Prognostic value of lymphocyte G protein-coupled receptor kinase-2 protein levels in patients with heart failure. Circ Res 118:1116\u20131124. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.115.308207","journal-title":"Circ Res"},{"key":"730_CR40","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1038\/sj.emboj.7601351","volume":"25","author":"A Salcedo","year":"2006","unstructured":"Salcedo A, Mayor F Jr, Penela P (2006) Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. EMBO J 25:4752\u20134762. \nhttps:\/\/doi.org\/10.1038\/sj.emboj.7601351","journal-title":"EMBO J"},{"key":"730_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-017-3253-0","author":"N Saleem","year":"2017","unstructured":"Saleem N, Prasad A, Goswami SK (2017) Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat. Mol Cell Biochem. \nhttps:\/\/doi.org\/10.1007\/s11010-017-3253-0","journal-title":"Mol Cell Biochem"},{"key":"730_CR42","doi-asserted-by":"publisher","first-page":"e0182110","DOI":"10.1371\/journal.pone.0182110","volume":"12","author":"P Schlegel","year":"2017","unstructured":"Schlegel P, Reinkober J, Meinhardt E, Tscheschner H, Gao E, Schumacher SM, Yuan A, Backs J, Most P, Wieland T, Koch WJ, Katus HA, Raake PW (2017) G protein-coupled receptor kinase 2 promotes cardiac hypertrophy. PLoS One 12:e0182110. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0182110","journal-title":"PLoS One"},{"key":"730_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12265-015-9646-0","volume":"8","author":"D Sorriento","year":"2015","unstructured":"Sorriento D, Santulli G, Franco A, Cipolletta E, Napolitano L, Gambardella J, Gomez-Monterrey I, Campiglia P, Trimarco B, Iaccarino G, Ciccarelli M (2015) Integrating GRK2 and NF\u03baB in the pathophysiology of cardiac hypertrophy. J Cardiovasc Transl Res 8:493\u2013502. \nhttps:\/\/doi.org\/10.1007\/s12265-015-9646-0","journal-title":"J Cardiovasc Transl Res"},{"key":"730_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/01.fjc.0000210074.56614.3b","volume":"47","author":"M Takahashi","year":"2006","unstructured":"Takahashi M, Tanonaka K, Yoshida H, Koshimizu M, Daicho T, Oikawa R, Takeo S (2006) Possible involvement of calpain activation in pathogenesis of chronic heart failure after acute myocardial infarction. J Cardiovasc Pharmacol 47:413\u2013421. \nhttps:\/\/doi.org\/10.1097\/01.fjc.0000210074.56614.3b","journal-title":"J Cardiovasc Pharmacol"},{"key":"730_CR45","doi-asserted-by":"publisher","first-page":"32170","DOI":"10.1074\/jbc.M111.248088","volume":"286","author":"M Taneike","year":"2011","unstructured":"Taneike M, Mizote I, Morita T, Watanabe T, Hikoso S, Yamaguchi O, Takeda T, Oka T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, Takeda J, Mochizuki N, Komuro I, Otsu K (2011) Calpain protects the heart from hemodynamic stress. J Biol Chem 286:32170\u201332177. \nhttps:\/\/doi.org\/10.1074\/jbc.M111.248088","journal-title":"J Biol Chem"},{"key":"730_CR46","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1074\/jbc.M509630200","volume":"281","author":"A Toth","year":"2006","unstructured":"Toth A, Nickson P, Qin LL, Erhardt P (2006) Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J Biol Chem 281:3679\u20133689. \nhttps:\/\/doi.org\/10.1074\/jbc.M509630200","journal-title":"J Biol Chem"},{"key":"730_CR47","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/01.CIR.87.2.454","volume":"87","author":"M Ungerer","year":"1993","unstructured":"Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87:454\u2013463. \nhttps:\/\/doi.org\/10.1161\/01.CIR.87.2.454","journal-title":"Circulation"},{"key":"730_CR48","doi-asserted-by":"publisher","first-page":"H1883","DOI":"10.1152\/ajpheart.00594.2015","volume":"309","author":"F Wan","year":"2015","unstructured":"Wan F, Letavernier E, Le Saux CJ, Houssaini A, Abid S, Czibik G, Sawaki D, Marcos E, Dubois-Rande JL, Baud L, Adnot S, Derumeaux G, Gellen B (2015) Calpastatin overexpression impairs postinfarct scar healing in mice by compromising reparative immune cell recruitment and activation. Am J Physiol Heart Circ Physiol 309:H1883\u2013H1893. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00594.2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"730_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jacbts.2018.05.004","volume":"3","author":"Y Wang","year":"2018","unstructured":"Wang Y, Chen B, Huang CK, Guo A, Wu J, Zhang X, Chen R, Chen C, Kutschke W, Weiss RM, Boudreau RL, Margulies KB, Hong J, Song LS (2018) Targeting calpain for heart failure therapy: implications from multiple murine models. JACC Basic Transl Sci 3:503\u2013517. \nhttps:\/\/doi.org\/10.1016\/j.jacbts.2018.05.004","journal-title":"JACC Basic Transl Sci"},{"key":"730_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3892\/ijmm_00000448","volume":"26","author":"D Yang","year":"2010","unstructured":"Yang D, Ma S, Tan Y, Li D, Tang B, Zhang X, Sun M, Yang Y (2010) Increased expression of calpain and elevated activity of calcineurin in the myocardium of patients with congestive heart failure. Int J Mol Med 26:159\u2013164. \nhttps:\/\/doi.org\/10.3892\/ijmm_00000448","journal-title":"Int J Mol Med"},{"key":"730_CR51","doi-asserted-by":"publisher","first-page":"e0120178","DOI":"10.1371\/journal.pone.0120178","volume":"10","author":"T Ye","year":"2015","unstructured":"Ye T, Wang Q, Zhang Y, Song X, Yang D, Li D, Li D, Su L, Yang Y, Ma S (2015) Over-expression of calpastatin inhibits calpain activation and attenuates post-infarction myocardial remodeling. PLoS One 10:e0120178. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0120178","journal-title":"PLoS One"},{"key":"730_CR52","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.molcel.2015.04.017","volume":"58","author":"Z Zha","year":"2015","unstructured":"Zha Z, Han X, Smith MD, Liu Y, Giguere PM, Kopanja D, Raychaudhuri P, Siderovski DP, Guan KL, Lei QY, Xiong Y (2015) A non-canonical function of Gbeta as a subunit of E3 ligase in targeting GRK2 ubiquitylation. Mol Cell 58:794\u2013803. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2015.04.017","journal-title":"Mol Cell"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-019-0730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00395-019-0730-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-019-0730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T11:11:56Z","timestamp":1573643516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00395-019-0730-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1007\/s00395-019-0730-5","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"21"}}